Adenosine-based cell therapy approaches for pharmacoresistant epilepsies
- PMID:17429216
- DOI: 10.1159/000100356
Adenosine-based cell therapy approaches for pharmacoresistant epilepsies
Abstract
Despite recent medical advances pharmacoresistant epilepsy continues to be a major health problem. The knowledge of endogenous protective mechanisms of the brain may lead to the development of rational therapies tailored to a patient's needs. Adenosine has been identified as an endogenous neuromodulator with antiepileptic and neuroprotective properties. However, the therapeutic use of adenosine or its receptor agonists is largely precluded by strong peripheral and central side effects. Thus, local delivery of adenosine to a critical site of the brain may provide a solution for the therapeutic use of adenosine. The following rationale for the local augmentation of the adenosine system as a novel therapeutic principle in the treatment of epilepsy has been established: (1) Deficits in the adenosinergic system are associated with epileptogenesis and these deficits promote seizures. Thus, reconstitution of an inhibitory adenosinergic tone is a rational therapeutic approach. (2) The focal paracrine delivery of adenosine from encapsulated cells suppresses seizures in kindled rats without overt side effects. (3) The anticonvulsant activity of locally released adenosine is maintained in models of epilepsy which are resistant to major antiepileptic drugs. This review summarizes the rationale and recent approaches for adenosine-based cell therapies for pharmacoresistant epilepsies.
(c) 2007 S. Karger AG, Basel.
Similar articles
- Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies.Boison D.Boison D.Neuroscientist. 2005 Feb;11(1):25-36. doi: 10.1177/1073858404269112.Neuroscientist. 2005.PMID:15632276Review.
- Adenosine kinase, epilepsy and stroke: mechanisms and therapies.Boison D.Boison D.Trends Pharmacol Sci. 2006 Dec;27(12):652-8. doi: 10.1016/j.tips.2006.10.008. Epub 2006 Oct 23.Trends Pharmacol Sci. 2006.PMID:17056128Review.
- Seizure suppression in kindled rats by intraventricular grafting of an adenosine releasing synthetic polymer.Boison D, Scheurer L, Tseng JL, Aebischer P, Mohler H.Boison D, et al.Exp Neurol. 1999 Nov;160(1):164-74. doi: 10.1006/exnr.1999.7209.Exp Neurol. 1999.PMID:10630201
- Modulatory role of adenosine and its receptors in epilepsy: possible therapeutic approaches.Pagonopoulou O, Efthimiadou A, Asimakopoulos B, Nikolettos NK.Pagonopoulou O, et al.Neurosci Res. 2006 Sep;56(1):14-20. doi: 10.1016/j.neures.2006.05.010. Epub 2006 Jul 18.Neurosci Res. 2006.PMID:16846657Review.
- Adenosinergic system as an endogenous anticonvulsant mechanism.Gupta YK, Malhotra J.Gupta YK, et al.Indian J Physiol Pharmacol. 1997 Oct;41(4):329-43.Indian J Physiol Pharmacol. 1997.PMID:10235655Review.
Cited by
- Uncoupling of astrogliosis from epileptogenesis in adenosine kinase (ADK) transgenic mice.Li T, Lan JQ, Boison D.Li T, et al.Neuron Glia Biol. 2008 May;4(2):91-9. doi: 10.1017/S1740925X09990135. Epub 2009 Aug 13.Neuron Glia Biol. 2008.PMID:19674507Free PMC article.
- Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice.Li T, Ren G, Lusardi T, Wilz A, Lan JQ, Iwasato T, Itohara S, Simon RP, Boison D.Li T, et al.J Clin Invest. 2008 Feb;118(2):571-82. doi: 10.1172/JCI33737.J Clin Invest. 2008.PMID:18172552Free PMC article.
- Neurabin scaffolding of adenosine receptor and RGS4 regulates anti-seizure effect of endogenous adenosine.Chen Y, Liu Y, Cottingham C, McMahon L, Jiao K, Greengard P, Wang Q.Chen Y, et al.J Neurosci. 2012 Feb 22;32(8):2683-95. doi: 10.1523/JNEUROSCI.4125-11.2011.J Neurosci. 2012.PMID:22357852Free PMC article.
- Adenosine dysfunction in astrogliosis: cause for seizure generation?Li T, Quan Lan J, Fredholm BB, Simon RP, Boison D.Li T, et al.Neuron Glia Biol. 2007 Nov;3(4):353-66. doi: 10.1017/S1740925X0800015X.Neuron Glia Biol. 2007.PMID:18634566Free PMC article.
- Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?Masino SA, Geiger JD.Masino SA, et al.Trends Neurosci. 2008 Jun;31(6):273-8. doi: 10.1016/j.tins.2008.02.009. Epub 2008 May 9.Trends Neurosci. 2008.PMID:18471903Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical